Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency

Journal of Clinical Gastroenterology

Volumn 40, Issue 8, 2006, Pages 721-725

  Vecht, Juda ^a   Symersky, Tomas ^a   Lamers, Cornelis B H W ^a   Masclee, Ad A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acid inhibition; Enzyme supplementation; Pancreatic exocrine insufficiency; Steatorrhoea

Indexed keywords

ACID; ELASTASE; FECES LIPID; OMEPRAZOLE; PANCREAS ENZYME; TRIACYLGLYCEROL LIPASE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INHIBITION; ENTERIC COATED TABLET; ENZYME INACTIVATION; FAT INTAKE; FEMALE; FLATULENCE; HUMAN; LIPID ABSORPTION; MALE; PANCREAS SECRETION; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; VISUAL ANALOG SCALE;

ADULT; AGED; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EXOCRINE PANCREATIC INSUFFICIENCY; FECES; FEMALE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; OMEPRAZOLE; PANCREATITIS; PANCRELIPASE; TREATMENT OUTCOME;

EID: 33748476674     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200609000-00012     Document Type: Article

References (24)

1. DiMagno EP, Go VLW, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Eng J Med. 1973;288:813-815.
2. Heizer WD, Cleaveland CR, Iber Fl. Gastric inactivation of pancreatic supplements. Bull John Hopkins Hosp. 1965;116:261-270.
3. Regan PT, Malagelada JR, DiMagno EP, et al. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med. 1977;297:854-858.
4. DiMagno EP, Malagelada JR, Go VL, et al. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977;296:1318-1322.
5. Layer P, Keller J. Lipase supplementation therapy: standards, alternatives, and perspectives. Pancreas. 2003;26:1-7.
6. Stead RJ, Skypala I, Hodson ME. Treatment of steatorrhea in cystic fibrosis: a comparison of enteric coated microspheres of pancreatin versus non-enteric coated pancreatin and adjuvant cimetidine. Aliment Pharmacol Ther. 1988;2:471-482.
7. 2-antagonists, and enteric coating. Dig Dis Sci. 1989;34:456-461.
8. Geus WP, Eddes EH, Gielkens HAJ, et al. Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis. Aliment Pharmacol Ther. 1999;13:937-943.
9. Bovo P, Cataudella G, DiFrancesco V, et al. Intraluminal gastric pH in chronic pancreatitis. Gut. 1995;36:294-298.
10. Heijerman HGM, Lamers CBHW, Bakker W. Omeprazole enhances the eficacy of pancreatin (Pancrease) in cystic fibrosis. Ann Int Med. 1991;114:200-201.
11. Carroccio A, Pardo F, Montalto G, et al. Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. Dig Dis Sci. 1992;37:1441-1446.
12. Bruno MJ, Rauws EAJ, Hoek FJ, et al. Comparative effects of adjuvant cimitidine and omeprazole during pancreatic enzyme replacement therapy. Dig Dis Sci. 1994;39:988-992.
13. Bruno MJ, Haverkort EB, Tijtgat GNJ, et al. Management of maldigestion associated with exocrine pancreatic insufficiency. Am J Gastroenterol. 1995;90:1383-1393.
14. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet. 1995;346:1247-1251.
15. Axon AT, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis; international definitions. Gut. 1984;25:1107-1112.
16. Scheefers-Borchel U, Scheefers H, Arnold R, et al. Pankreatische Elastase 1: parameter für die chronische und akute Pankreatitis. Lab Med. 1992;16:427-432.
17. Symersky T, van der Zon A, Biemond I, et al. Faecal elastase-I: helpful in analyzing steatorrhoea? Neth J Med. 2004;62:286-290.
18. Kölbel C, Layer P, Hotz J. Pancreatic steatorrhoea treated by enteric-coated microspheric pancreatin. Med Klin. 1986;3:85-86.
19. Regan PT, Malagelada JR, DiMagno EP, et al. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology. 1979;77:285-289.
20. Andersen JR, Bendtsen F, Ovesen L, et al. Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization. Int J Pancreatol. 1990;6:263-270.
21. Walt RP, Gomes MDFA, Wood EC, et al. Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J. 1983;287:12-14.
22. Naesdal J, Bodemar G, Walan A. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol. 1984;19:916-922.
23. Olbe L, Lind T, Cederberg C, et al. Effect of omeprazole on gastric acid secretion in man. Scand J Gastroenterol. 1986;21(Suppl):105-107.
24. Heijerman HG, Lamers CB, Bakker W, et al. Improvement of fecal fat excretion after addition of omeprazole to Pancrease in cystic fibrosis is related to residual exocrine function of the pancreas. Dig Dis Sci. 1993;38:1-6.